Drug intelligence / Profile preview

Aptamin C

Development stage
Preclinical
Lead developer
N Therapeutics
Modality
RNA Aptamers → RNA Therapeutics → Nucleic Acid Therapeutics, DNA Aptamers → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Oral, Topical
01

Overview

Aptamin C is an innovative single-stranded DNA aptamer (specifically s-DNA Aptamer-2) developed by Nexmos that binds to the reduced form of vitamin C (ascorbic acid) to stabilize it and delay its oxidation. By preventing oxidative degradation, Aptamin C maximizes the antioxidant, anti-inflammatory, and immunomodulatory efficacy of vitamin C. It is developed as a dietary supplement, cosmetic ingredient, and therapeutic agent. In clinical and preclinical studies, Aptamin C has demonstrated efficacy in enhancing natural killer (NK) cell activity, improving skin conditions such as atopic dermatitis and pruritus, and, in combination with vitamin C (as NXP031), providing neuroprotective effects in models of Parkinson's disease, Alzheimer's disease, and vascular dementia.

Brand names
Aptamin C
Other names
S-Dna Aptamer-2vitamin C-DNA aptamer complexvitamin C-DNA complex

Beyond the preview

Go deeper on Aptamin C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aptamin C.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call